![]() |
|
|
Forward to a colleague |
||
Access Full Stories Packaging giant Gerresheimer crowned its first year as a public company with a leap in profits for the fourth quarter of 2007, helped by its acquisition of plastic specialist Wilden Group... Read Investigation fingers Cambrex for safety breach after plant explosion An investigation in the aftermath of a fire and explosion at one of Cambrex' US plants last year has found the firm in breach of several safety regulations and the company will be fined accordingly... Read H&R Wasag stays positive as oil prices bite in pharma Oil price fluctuations had the expected impact of dampening profits in H&R Wasag's key chemical-pharmaceutical raw materials business during 2007... Read Genmab slakes capacity thirst with PDL facility purchase Genmab, the Danish antibody specialist with three product candidates in Phase III clinical trials, is taking control of its manufacturing requirements with the agreed acquisition of an antibody facility in Minnesota,... Read BASF sees hefty chemicals growth in 2007 Earnings growth from its pharma solutions business helped push BASF's operating income (EBITDA) from fine chemicals up by 56.5 per cent to €288m in 2007... Read |
||||||||||||||||||
All News Headlines for: February | January | December |
||||||||||||||||||
![]() Why outsource GMP audits? Outsourcing GMP audits can help harmonize quality compliance within supply chains. These audit solutions can be provided in a globally consistent and independent manner while appreciating the cultural and regulatory differences. Join FREE webinar for more... Click Here | ||||||||||||||||||
|
Related Industry News Covance triumphant in animal lab battle Covance has emerged triumphant in the latest episode of a long-lasting saga over a new US animal testing lab that it is building in Chandler, Arizona... Read India's largest CRAMS firm gathers momentum Jubilant Organosys, India's largest custom research and manufacturing services (CRAMS) provider, has scored new contracts to the tune of $92m for the year thus far as its business continues to gather momentum... Read Eisai inks Japan's first major India data deal Japan's Eisai has inked a deal with Accenture to have it provide it with global clinical data management services from India, and becomes the first big Japanese pharma firm to take such a step... Read Novel genetic technique 'creates' stem cells Scientists can now transform adult cells to a stem cell-like state without using a cancer inducing gene. Researchers at Harvard University said they can now map the stages of the reprogramming which had thus... Read
|
||||||||||||||||||
|
|||||
Forward to a colleague |
|||||
To continue to receive this newsletter in your inbox, please add newsletter@In-PharmaTechnologist.com to your address book |
||
Update preferences | Change your email address | Unsubscribe |
||
Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback |
||
| © 2008 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com |
||